Personalized Antisense Oligonucleotide for a Single Participant With CHCHD10 ALS
Clinical trial NCT06977451 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06977451
- Sponsor
- n-Lorem Foundation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-24
- Primary completion
- 2027-06-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.